F/m Emerald Life Sciences Innovation ETF
LFSC
8 hedge funds and large institutions have $100M invested in F/m Emerald Life Sciences Innovation ETF in 2026 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
32% more capital invested
Capital invested by funds: $75.5M → $100M (+$24.5M)
14% more funds holding
Funds holding: 7 → 8 (+1)
5.17% more ownership
Funds ownership: 76.92% → 82.09% (+5.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
+$949K |
| 2 |
OPA
Old Port Advisors
Portland,
Maine
|
+$875K |
| 3 |
HAIM
Hunter Associates Investment Management
Pittsburgh,
Pennsylvania
|
+$310K |
| 4 |
AI
Atria Investments
Charlotte,
North Carolina
|
+$83.6K |
| 5 |
CCWP
Cedar Cove Wealth Partners
Bloomington,
Minnesota
|
+$5.11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Tidal Investments
Milwaukee,
Wisconsin
|
-$96.1K |
| 2 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$3.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$735 |
LFSC Hedge Fund Activity: Q2 2026 in Review
8 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in F/m Emerald Life Sciences Innovation ETF (LFSC) for Q2 2026, worth a combined $100M — up 32% from $75.5M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new LFSC positions and 2 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.
The largest buyer was IHT Wealth Management, opening a new position worth an estimated $949K. The largest seller was Tidal Investments, cutting an estimated $96.1K.
- 8 institutional investors held F/m Emerald Life Sciences Innovation ETF (LFSC) as of Q2 2026, up from 7 in Q1 2026.
- Funds reported $100M of F/m Emerald Life Sciences Innovation ETF stock for Q2 2026, up 32% quarter-over-quarter.
- 3 funds opened new F/m Emerald Life Sciences Innovation ETF positions in Q2 2026 and 2 closed out, a net change of +1 holder.
- The largest F/m Emerald Life Sciences Innovation ETF buyer in Q2 2026 was IHT Wealth Management, an estimated $949K added.
- The largest F/m Emerald Life Sciences Innovation ETF seller in Q2 2026 was Tidal Investments, an estimated $96.1K sold.
Based on aggregated 13F filings for Q2 2026.